Ifp Advisors, Inc Citius Pharmaceuticals, Inc. Transaction History
Ifp Advisors, Inc
- $2.91 Billion
- Q4 2024
A detailed history of Ifp Advisors, Inc transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 33,333 shares of CTXR stock, worth $59,999. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33,333
Previous 33,333
-0.0%
Holding current value
$59,999
Previous $16,000
731.25%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CTXR
# of Institutions
7Shares Held
2.32MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY1.81MShares$3.25 Million0.0% of portfolio
-
Chelsea Counsel CO281KShares$506,3400.07% of portfolio
-
Key Bridge Compliance, LLC Covington, KY154KShares$277,4340.03% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ40.3KShares$72,5090.0% of portfolio
-
American Portfolios Advisors Holbrook, NY4KShares$7,2000.0% of portfolio
About Citius Pharmaceuticals, Inc.
- Ticker CTXR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 146,130,000
- Market Cap $263M
- Description
- Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...